Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.

Washington (DC): National Academies Press (US); 2009.

2.

The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies.

Institute of Medicine (US) Forum on Microbial Threats.

Washington (DC): National Academies Press (US); 2011.

3.

The role of academic institutions in the development of drugs for rare and neglected diseases.

Coles LD, Cloyd JC.

Clin Pharmacol Ther. 2012 Aug;92(2):193-202. doi: 10.1038/clpt.2012.83. Epub 2012 Jul 4. Review.

PMID:
22760003
4.

Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation, Institute of Medicine (US) Forum on Medical and Public Health Preparedness for Catastrophic Events.

Washington (DC): National Academies Press (US); 2011.

5.

[Aiming for zero blindness].

Nakazawa T.

Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194. Review. Japanese.

PMID:
25854109
6.

CNS Clinical Trials: Suicidality and Data Collection, Workshop Summary.

Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders.

Washington (DC): National Academies Press (US); 2010.

7.

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary.

Institute of Medicine (US).

Washington (DC): National Academies Press (US); 2012.

8.

Measuring the Impacts of Federal Investments in Research: A Workshop Summary.

National Academies (US) Committee on Measuring Economic and Other Returns on Federal Research Investments.

Washington (DC): National Academies Press (US); 2011.

9.

The use of the United States FDA programs as a strategy to advance the development of drug products for neglected tropical diseases.

Sachs-Barrable K, Conway J, Gershkovich P, Ibrahim F, Wasan KM.

Drug Dev Ind Pharm. 2014 Nov;40(11):1429-34. doi: 10.3109/03639045.2014.884132. Epub 2014 Feb 11. Review.

PMID:
24512098
10.

Emerging Safety Science: Workshop Summary.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.

Washington (DC): National Academies Press (US); 2008.

11.

Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.

Washington (DC): National Academies Press (US); 2010.

12.

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary.

Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine.

Washington (DC): National Academies Press (US); 2014 Dec 19.

13.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
14.

Expedited Programs for Serious Conditions: An Update on Breakthrough Therapy Designation.

Kwok M, Foster T, Steinberg M.

Clin Ther. 2015 Sep;37(9):2104-20. doi: 10.1016/j.clinthera.2015.07.011. Epub 2015 Aug 18. Review.

PMID:
26297571
15.

Large Simple Trials and Knowledge Generation in a Learning Health System: Workshop Summary.

Roundtable on Value and Science-Driven Health Care, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine.

Washington (DC): National Academies Press (US); 2013 Dec 5.

16.

Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.

Washington (DC): National Academies Press (US); 2011.

17.

Enabling Rapid and Sustainable Public Health Research During Disasters: Summary of a Joint Workshop by the Institute of Medicine and the U.S. Department of Health and Human Services.

Forum on Medical and Public Health Preparedness for Catastrophic Events, Board on Health Sciences Policy, Institute of Medicine.

Washington (DC): National Academies Press (US); 2015 Apr 6.

18.

Identifying and Reducing Environmental Health Risks of Chemicals in Our Society: Workshop Summary.

Roundtable on Environmental Health Sciences, Research, and Medicine, Board on Population Health and Public Health Practice, Institute of Medicine.

Washington (DC): National Academies Press (US); 2014 Oct 2.

19.

International Regulatory Harmonization Amid Globalization of Drug Development: Workshop Summary.

Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine (IOM); Weisfeld V, Lustig TA, editors.

Washington (DC): National Academies Press (US); 2013 Oct 24.

20.

Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.

Coffey CS, Levin B, Clark C, Timmerman C, Wittes J, Gilbert P, Harris S.

Clin Trials. 2012 Dec;9(6):671-80. doi: 10.1177/1740774512461859.

PMID:
23250942

Supplemental Content

Support Center